CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 124 filers reported holding CARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,426,068 | -16.2% | 1,444,088 | +41.2% | 0.01% | -17.6% |
| Q2 2023 | $2,894,756 | -74.1% | 1,022,882 | +11.4% | 0.02% | -77.3% |
| Q1 2022 | $11,157,000 | -1.0% | 918,256 | -0.8% | 0.08% | 0.0% |
| Q4 2021 | $11,272,000 | -18.1% | 925,482 | +3.9% | 0.08% | -19.4% |
| Q3 2021 | $13,765,000 | +175.9% | 890,943 | +154.8% | 0.09% | +173.5% |
| Q2 2021 | $4,990,000 | -62.3% | 349,668 | -42.6% | 0.03% | -66.7% |
| Q1 2021 | $13,228,000 | +70.6% | 609,295 | +18.9% | 0.10% | +50.0% |
| Q4 2020 | $7,754,000 | +58.4% | 512,496 | +33.2% | 0.07% | +33.3% |
| Q3 2020 | $4,896,000 | +469.3% | 384,751 | +664.9% | 0.05% | +466.7% |
| Q2 2020 | $860,000 | +1265.1% | 50,303 | +284.0% | 0.01% | +800.0% |
| Q2 2016 | $63,000 | -43.8% | 13,100 | -27.2% | 0.00% | -50.0% |
| Q1 2016 | $112,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |